Pemigatinib

Overview

Pemigatinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4297522).

API suppliers (1)

Suppliers of Pemigatinib backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• MSN Laboratories Private LimitedIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (3 approved US products), the latest listed US patent on Pemigatinib expires 3 Oct 2040 and exclusivity 26 Aug 2029. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

11-(2,6-difluoro-3,5-dimethoxyphenyl)-13-ethyl-4-(morpholin-4-ylmethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-12-one

Canonical SMILES

CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5

InChIKey

HCDMJFOHIXMBOV-UHFFFAOYSA-N